Elemind Technologies
Elemind is a pioneering neurotechnology company that develops wearable neuromodulation devices to improve sleep and other brain functions, mimicking pharmaceutical benefits without negative side effects. Their core product, the Elemind headband, uses EEG brain signal measurement and precise acoustic stimulation to help users fall asleep faster and restart sleep if they wake up. Clinically shown to help 76% of study participants fall asleep significantly faster, Elemind is drug-free and designed for comfort in all sleeping positions. The company is backed by 5 years of research and testing, and their AI Sleep Tailor personalizes the experience by learning from user sleep patterns. Beyond sleep, Elemind's technology has been explored for suppressing Essential Tremor, increasing pain thresholds, augmenting anesthesia, and boosting memory formation, with academic institutions and health systems partnering to validate and build applications for their technology.
Elemind Technologies
Elemind is a pioneering neurotechnology company that develops wearable neuromodulation devices to improve sleep and other brain functions, mimicking pharmaceutical benefits without negative side effects. Their core product, the Elemind headband, uses EEG brain signal measurement and precise acoustic stimulation to help users fall asleep faster and restart sleep if they wake up. Clinically shown to help 76% of study participants fall asleep significantly faster, Elemind is drug-free and designed for comfort in all sleeping positions. The company is backed by 5 years of research and testing, and their AI Sleep Tailor personalizes the experience by learning from user sleep patterns. Beyond sleep, Elemind's technology has been explored for suppressing Essential Tremor, increasing pain thresholds, augmenting anesthesia, and boosting memory formation, with academic institutions and health systems partnering to validate and build applications for their technology.
TL;DR
Headquarters: Cambridge, Massachusetts
Product: Wearable EEG headband that delivers phase-locked acoustic neuromodulation to accelerate sleep onset
Clinical evidence: Company reports ~76% of study participants fell asleep faster in clinical studies
Business model: Direct-to-consumer hardware sales with optional subscription app membership
Team size: Approximately 12 employees
Company Overview
Problem Domain
Sleep improvement and broader neuromodulation applications (e.g., essential tremor suppression, pain threshold modulation, anesthesia augmentation, memory augmentation).
Industry
Neurotechnology / Sleep tech
Tech Stack
Funding Track Record
Seed round activity noted in February 2024; multiple investors reported across seed activity
Investor Signal
“Investors reported include Wharton Angel Network, Village Global, LDV Partners, Embark Ventures, and E14 Fund”